B-cell prolymphocytic leukemia (B-PLL) is a rare disease, accounting for 1% of the chronic lymphoid leukemias. First described in the early seventies, 1, 2 B-PLL is now recognized as a specific entity ...

Although clonal heterogeneity or finding two or more IgVH clones in cases of sporadic MBL has previously been reported, 8 those studies used techniques that were not particularly sensitive and started ...

Patterns of hepatitis B reactivation and liver test abnormalities in patients with chronic lymphocytic leukemia (CLL) treated with idelalisib plus an anti-CD20 antibody. Checkmate 205: Nivolumab (nivo ...

Cytarabine Dose of 36 g/m2 Compared With 12 g/m2 Within First Consolidation in Acute Myeloid Leukemia: Results of Patients Enrolled Onto the Prospective Randomized AML96 Study With this report, we ...

Susan M. O’Brien, MD: I think that the single agents, in terms of the targeted therapies, have proven to be very effective in CLL. But, I also think that there’s room for improvement. For example, ...